In this report, The global Artificial Joint Replacement market is valued at 2673 K Units in 2019 and will reach 4623 K Units by the end of 2025, growing at a CAGR of 5.66% during 2020-2025.
A joint is where the ends of two or more bones meet. There are different types of joints within the body. For example, the knee is considered a ""hinge"" joint, because of its ability to bend and straighten like a hinged door. The hip and shoulder are ""ball-and-socket"" joints, in which the rounded end of one bone fits into a cup-shaped area of another bone.
Hip and knee replacements are the most commonly performed joint replacements, but replacement surgery can be performed on other joints, as well, including the ankle, wrist, shoulder, and elbow. Most important types of Artificial Joint Replacement products covered in this report are: Knee Joint, Ankle Joint , Shoulder Joint  and others.
Most widely used downstream fields of Artificial Joint Replacement market covered in this report are: Hospitals, Orthopedic Centers, Ambulatory Surgery Center and Others. Increasing use of Artificial Joint Replacement in hospital to help with strong demand. The production regions mainly focus on USA and Europe. USA-based Zimmer, J&J, and Stryker are the leader manufacturers in global. In the past years, the three biggest suppliers of Artificial Joint Replacement take 56% of global Artificial Joint Replacement production.
Hip and knee replacements stand out as the most common types of joint replacements, with a substantial number of patients undergoing these procedures to address conditions such as osteoarthritis and femoral neck trauma. The necessity for hip or knee surgery often arises from factors that compromise joint function and cause significant discomfort. Osteoarthritis, a degenerative joint disease, and femoral neck injuries are among the leading causes that prompt individuals to seek joint replacement surgery.
Typically, patients undergoing their first hip or knee replacement surgery are in the age range of 60 to 70 years. Furthermore, a significant portion of individuals requiring arthroplasty due to femoral neck injuries falls into an even older demographic, with two-thirds of patients being above the age of 85 years. This demographic trend reflects the prevalence of joint-related issues in the elderly population, where the wear and tear on joints over time, coupled with the increased risk of accidents, contribute to the need for surgical interventions.
Femoral neck fractures, a common indication for joint replacement, particularly in the elderly, necessitate surgical intervention for optimal outcomes. The primary objectives of joint replacement surgery, in the context of femoral neck fractures, are to enhance the patient's overall quality of life. This involves restoring maximum functionality, improving mobility, alleviating pain, ensuring a prolonged service life of the joint replacement, maintaining good muscle mass capacity, and preventing potential secondary complications.
The impact of the COVID-19 pandemic on the orthopedic surgery market, particularly in the context of joint replacements, has varied across different regions. In the Asia Pacific, sales losses related to joint replacements have seen a less severe reduction compared to other foreign markets. This resilience could be attributed to effective pandemic management, robust healthcare infrastructure, or other regional factors that mitigated the downturn.
The United States market experienced sales losses during the pandemic; however, a robust rebound in the third quarter of a specific year helped offset some of the annual declines. Despite challenges, there is optimism for more stable orthopedic surgery numbers in the second half of 2021, and projections suggest a more consistent income for device makers in 2022. This anticipated stability reflects both the resilience of the market and the adaptability of healthcare systems to challenging circumstances, ultimately ensuring continued access to essential joint replacement surgeries.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Artificial Joint Replacement in these regions, from 2014 to 2026 (forecast), covering Asia-Pacific (China, Japan, Korea, India and Southeast Asia) North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) South America (Brazil, Argentina, Columbia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Artificial Joint Replacement market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer.
The top players including Zimmer J&J Stryker Smith & Nephew Kyocera Aesculap Wright Medical AK Medical WEGO Medical Excellence JAPAN Total Ankle Institute Integra ZT Medical Teijin Link
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Knee Joint Ankle Joint Shoulder Joint Hip Joint Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Artificial Joint Replacement for each application, including Hospitals Orthopedic Centers Ambulatory Surgery Center Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Artificial Joint Replacement Market by Manufacturers, Regions, Type and Application, Forecast to 2026 1 Report Overview 1.1 Definition and Specification 1.2 Report Overview 1.2.1 Manufacturers Overview 1.2.2 Regions Overview 1.2.3 Type Overview 1.2.4 Application Overview 1.3 Industrial Chain 1.3.1 Artificial Joint Replacement Overall Industrial Chain 1.3.2 Upstream 1.3.3 Downstream 1.4 Industry Situation 1.4.1 Industrial Policy 1.4.2 Product Preference 1.4.3 Economic/Political Environment 1.5 SWOT Analysis
2 Market Assessment by Type 2.1 Knee Joint Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020 2.2 Ankle Joint Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020 2.3 Shoulder Joint Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020 2.4 Hip Joint Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020 2.5 Other Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Artificial Joint Replacement Market Assessment by Type 3.1 Asia Pacific Market Performance (Sales, Revenue) 3.2 Key Players in Asia Pacific
4 North America Artificial Joint Replacement Market Assessment by Type 4.1 North America Market Performance (Sales, Revenue) 4.2 Key Players in North America
5 Europe Artificial Joint Replacement Market Assessment by Type 4.1 Europe Market Performance (Sales, Revenue) 4.2 Key Players in Europe
6 South America Artificial Joint Replacement Market Assessment by Type 4.1 South America Market Performance (Sales, Revenue) 4.2 Key Players in South America
7 Middle Easr and Africa Artificial Joint Replacement Market Assessment by Type 4.1 Middle Easr and Africa Market Performance (Sales, Revenue) 4.2 Key Players in Middle Easr and Africa
8 World Artificial Joint Replacement Market Assessment by Type 8.1 Asia Pacific Artificial Joint Replacement Market Assessment by Application (Consumption and Market Share) 8.2 North America Artificial Joint Replacement Market Assessment by Application (Consumption and Market Share) 8.3 Europe Artificial Joint Replacement Market Assessment by Application (Consumption and Market Share) 8.4 South America Artificial Joint Replacement Market Assessment by Application (Consumption and Market Share) 8.5 Middle East and Africa Artificial Joint Replacement Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis 9.1 Zimmer 9.1.1 Zimmer Profiles 9.1.2 Zimmer Product Portfolio 9.1.3 Zimmer Artificial Joint Replacement Business Performance 9.1.4 Zimmer Artificial Joint Replacement Business Development and Market Status 9.2 J&J 9.2.1 J&J Profiles 9.2.2 J&J Product Portfolio 9.2.3 J&J Artificial Joint Replacement Business Performance 9.2.4 J&J Artificial Joint Replacement Business Development and Market Status 9.3 Stryker 9.3.1 Stryker Profiles 9.3.2 Stryker Product Portfolio 9.3.3 Stryker Artificial Joint Replacement Business Performance 9.3.4 Stryker Artificial Joint Replacement Business Development and Market Status 9.4 Smith & Nephew 9.4.1 Smith & Nephew Profiles 9.4.2 Smith & Nephew Product Portfolio 9.4.3 Smith & Nephew Artificial Joint Replacement Business Performance 9.4.4 Smith & Nephew Artificial Joint Replacement Business Development and Market Status 9.5 Kyocera 9.5.1 Kyocera Profiles 9.5.2 Kyocera Product Portfolio 9.5.3 Kyocera Artificial Joint Replacement Business Performance 9.5.4 Kyocera Artificial Joint Replacement Business Development and Market Status 9.6 Aesculap 9.6.1 Aesculap Profiles 9.6.2 Aesculap Product Portfolio 9.6.3 Aesculap Artificial Joint Replacement Business Performance 9.6.4 Aesculap Artificial Joint Replacement Business Development and Market Status 9.7 Wright Medical 9.7.1 Wright Medical Profiles 9.7.2 Wright Medical Product Portfolio 9.7.3 Wright Medical Artificial Joint Replacement Business Performance 9.7.4 Wright Medical Artificial Joint Replacement Business Development and Market Status 9.8 AK Medical 9.8.1 AK Medical Profiles 9.8.2 AK Medical Product Portfolio 9.8.3 AK Medical Artificial Joint Replacement Business Performance 9.8.4 AK Medical Artificial Joint Replacement Business Development and Market Status 9.9 WEGO 9.9.1 WEGO Profiles 9.9.2 WEGO Product Portfolio 9.9.3 WEGO Artificial Joint Replacement Business Performance 9.9.4 WEGO Artificial Joint Replacement Business Development and Market Status 9.10 Medical Excellence JAPAN 9.10.1 Medical Excellence JAPAN Profiles 9.10.2 Medical Excellence JAPAN Product Portfolio 9.10.3 Medical Excellence JAPAN Artificial Joint Replacement Business Performance 9.10.4 Medical Excellence JAPAN Artificial Joint Replacement Business Development and Market Status 9.11 Total Ankle Institute 9.12 Integra 9.13 ZT Medical 9.14 Teijin 9.15 Link
10 World Artificial Joint Replacement Market Assessment by Players 10.1 Global Artificial Joint Replacement Sales (K Units) and Market Share by Players 2014-2020 10.2 Global Artificial Joint Replacement Revenue (M USD) and Market Share by Players 2014-2020 10.3 Global Artificial Joint Replacement Price (USD/Unit) of Players 2014-2020 10.4 Global Artificial Joint Replacement Gross Margin of Players 2014-2020 10.5 Market Concentration
11 Regional Market Performance by Segment of Players 11.1 North America 11.1.1 North America Artificial Joint Replacement Sales Assessment of Players 2014-2020 11.1.2 North America Artificial Joint Replacement Revenue Assessment of Players 2014-2020 11.1.3 North America Artificial Joint Replacement Price Assessment of Players 2014-2020 11.1.4 North America Artificial Joint Replacement Gross Margin Assessment of Players 2014-2020 11.1.5 Market Concentration 11.2 Europe 11.2.1 Europe Artificial Joint Replacement Sales Assessment of Players 2014-2020 11.2.2 Europe Artificial Joint Replacement Revenue Assessment of Players of Manufacturers 2014-2020 11.2.3 Europe Artificial Joint Replacement Price Assessment of Players 2014-2020 11.2.4 Europe Artificial Joint Replacement Gross Margin Assessment of Players 2014-2020 11.2.5 Market Concentration 11.3 Asia-Pacific Market Performance for Manufacturers 11.3.1 Asia-Pacific Artificial Joint Replacement Sales Assessment of Players 2014-2020 11.3.2 Asia-Pacific Artificial Joint Replacement Revenue Assessment of Players 2014-2020 11.3.3 Asia-Pacific Artificial Joint Replacement Price Assessment of Players 2014-2020 11.3.4 Asia-Pacific Artificial Joint Replacement Gross Margin Assessment of Players 2014-2020 11.3.5 Market Concentration 11.4 South America Market Performance for Players 11.4.1 South America Artificial Joint Replacement Sales Assessment of Players 2014-2020 11.4.2 South America Artificial Joint Replacement Revenue Assessment of Players 2014-2020 11.4.3 South America Artificial Joint Replacement Price Assessment of Players 2014-2020 11.4.4 South America Artificial Joint Replacement Gross Margin Assessment of Players 2014-2020 11.4.5 Market Concentration 11.5 Middle East and Africa Market Performance for Players 11.5.1 Middle East and Africa Artificial Joint Replacement Sales Assessment of Players 2014-2020 11.5.2 Middle East and Africa Artificial Joint Replacement Revenue Assessment of Players 2014-2020 11.5.3 Middle East and Africa Artificial Joint Replacement Price Assessment of Players 2014-2020 11.5.4 Middle East and Africa Artificial Joint Replacement Gross Margin Assessment of Players 2014-2020 11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries 12.1 Asia Pacific 12.1.1 Asia Pacific Artificial Joint Replacement Sales by Countries/Regions 2014-2020 12.1.2 Asia Pacific Artificial Joint Replacement Revenue by Countries/Regions 2014-2020 12.1.3 Asia Pacific Artificial Joint Replacement Average Price by Countries/Regions 2014-2020 12.2 North America 12.2.1 North America Artificial Joint Replacement Sales by Countries/Regions 2014-2020 12.2.2 North America Artificial Joint Replacement Revenue by Countries/Regions 2014-2020 12.2.3 North America Artificial Joint Replacement Average Price by Countries/Regions 2014-2020 12.3 Europe 12.3.1 Europe Artificial Joint Replacement Sales by Countries/Regions 2014-2020 12.3.2 Europe Artificial Joint Replacement Revenue by Countries/Regions 2014-2020 12.3.3 Europe Artificial Joint Replacement Average Price by Countries/Regions 2014-2020 12.4 South America 12.4.1 South America Artificial Joint Replacement Sales by Countries/Regions 2014-2020 12.4.2 South America Artificial Joint Replacement Revenue by Countries/Regions 2014-2020 12.4.3 South America Artificial Joint Replacement Average Price by Countries/Regions 2014-2020 12.5 Middle East and Africa 12.5.1 Middle East and Africa Artificial Joint Replacement Sales by Countries/Regions 2014-2020 12.5.2 Middle East and Africa Artificial Joint Replacement Revenue by Countries/Regions 2014-2020 12.5.3 Middle East and Africa Artificial Joint Replacement Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity 13.1 Technology 13.2 Market Opportunity
14 World Artificial Joint Replacement Sales & Revenue Forecast 2021-2026 14.1 World Artificial Joint Replacement Sales and Revenue Forecast by Regions 2021-2026 14.1.1 World Artificial Joint ReplacementSales and Market Share by Regions 14.1.2 World Artificial Joint ReplacementRevenue and Market Share by Regions
15 Asia Artificial Joint Replacement Market Forecast 2021-2026 15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026 15.1.1 Knee Joint 15.1.2 Ankle Joint 15.1.3 Shoulder Joint 15.1.4 Hip Joint 15.1.5 Other 15.2 Consumption Forecast by Application, 2021-2026
16 North America Artificial Joint Replacement Market Forecast 2021-2026 16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026 16.1.1 Knee Joint 16.1.2 Ankle Joint 16.1.3 Shoulder Joint 16.1.4 Hip Joint 16.1.5 Other 16.2 Consumption Forecast by Application, 2021-2026
17 Europe Artificial Joint Replacement Market Forecast 2021-2026 17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026 17.1.1 Knee Joint 17.1.2 Ankle Joint 17.1.3 Shoulder Joint 17.1.4 Hip Joint 17.1.5 Other 17.2 Consumption Forecast by Application, 2021-2026
18 South America Artificial Joint Replacement Market Forecast 2021-2026 18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026 18.1.1 Knee Joint 18.1.2 Ankle Joint 18.1.3 Shoulder Joint 18.1.4 Hip Joint 18.1.5 Other 18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Artificial Joint Replacement Market Forecast 2021-2026 19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026 19.1.1 Knee Joint 19.1.2 Ankle Joint 19.1.3 Shoulder Joint 19.1.4 Hip Joint 19.1.5 Other 19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast 20.1 Global Artificial Joint Replacement Price (USD/Unit) Trend 2021-2026 20.2 Global Artificial Joint Replacement Gross Profit Trend 2021-2026